Highlights

Research is key to future treatment

Our six research themes and two cross-cutting themes bring together a critical mass of internationally renowned clinicians, scientists and allied health professionals, allowing us to ensure that novel diagnostics and physical and systemic therapies are rapidly available to all cancer patients.

Our research

Patient and public involvement and engagement

Involving patients and the public with our research ensures that we focus on the issues that matter most to those affected by cancer.

Find out more

Latest news

MHRA approves 'search and destroy' prostate cancer treatment

177Lu-PSMA-617, a highly targeted radioactive drug, has been approved by the medicines regulator, the MHRA, for some patients with advanced prostate cancer.

Study suggests robotic surgery has high cure rates for some head and neck cancer patients

Robotic surgery can improve survival rates and reduce recovery time for some people with recurrent head and neck cancers, suggests a pioneering new international study led by researchers at The Royal Marsden.

Olaparib for high-risk, early-stage breast cancer approved in Europe

Olaparib has been approved in Europe for people with high-risk, early-stage breast cancer who have inherited faults in their BRCA1 or BRCA2 genes.